MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF
申请人:Gene Logic, Inc.
公开号:EP1644337A1
公开(公告)日:2006-04-12
US7375125B2
申请人:——
公开号:US7375125B2
公开(公告)日:2008-05-20
[EN] MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSES DE LIAISON DU RECEPTEUR DE LA MELANOCORTINE-4 ET LEURS PROCEDES D'UTILISATION
申请人:GENE LOGIC INC
公开号:WO2005121100A1
公开(公告)日:2005-12-22
Provided are MC4-R binding compounds of the formula XVII: (XVII), wherein L2 is a linker group, and P1, P2, P3, P4, Z1, Z2, Z3, Z4, Z5, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.
Melanocortin-4 receptor binding compounds and methods of use thereof
申请人:Millennium Pharmaceuticals, Inc.
公开号:US20040082779A1
公开(公告)日:2004-04-29
Provided are MC4-R binding compounds of the formula XVII:
1
wherein L
2
is a linker group, and P
1
, P
2
, P
3
, P
4
, Z
1
, Z
2
, Z
3
, Z
4
, Z
5
, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.